Clinical trial NCT03303053 - References

Graves Disease — Efficacy and Safety of Cholestyramine and Prednisolone as Adjunctive Therapy in Treatment of Overt Hyperthyroidism

Citation(s)

•   Baeza A, Aguayo J, Barria M, Pineda G
  Rapid preoperative preparation in hyperthyroidism. Clin Endocrinol (Oxf). 1991 Nov;35(5):439-42.
•   Conn HO, Poynard T
  Corticosteroids and peptic ulcer: meta-analysis of adverse events during steroid therapy. J Intern Med. 1994 Dec;236(6):619-32.
•   Dahl P, Danzi S, Klein I
  Thyrotoxic cardiac disease. Curr Heart Fail Rep. 2008 Sep;5(3):170-6. Review.
•   Frost L, Vestergaard P, Mosekilde L
  Hyperthyroidism and risk of atrial fibrillation or flutter: a population-based study. Arch Intern Med. 2004 Aug 9-23;164(15):1675-8. Erratum in: Arch Intern Med. 2005 Feb 14;165(3):307.
•   Garmendia Madariaga A, Santos Palacios S, Guillén-Grima F, Galofré JC
  The incidence and prevalence of thyroid dysfunction in Europe: a meta-analysis. J Clin Endocrinol Metab. 2014 Mar;99(3):923-31. doi: 10.1210/jc.2013-2409. Epub 2014 Jan 1.
•   Hollowell JG, Staehling NW, Flanders WD, Hannon WH, Gunter EW, Spencer CA, Braverman LE
  Serum TSH, T(4), and thyroid antibodies in the United States population (1988 to 1994): National Health and Nutrition Examination Survey (NHANES III). J Clin Endocrinol Metab. 2002 Feb;87(2):489-99.
•   Jude EB, Dale J, Kumar S, Dodson PM
  Treatment of thyrotoxicosis resistant to carbimazole with corticosteroids. Postgrad Med J. 1996 Aug;72(850):489-91.
•   Kaykhaei MA, Shams M, Sadegholvad A, Dabbaghmanesh MH, Omrani GR
  Low doses of cholestyramine in the treatment of hyperthyroidism. Endocrine. 2008 Aug-Dec;34(1-3):52-5. doi: 10.1007/s12020-008-9107-5. Epub 2008 Oct 23.
•   Mercado M, Mendoza-Zubieta V, Bautista-Osorio R, Espinoza-de los Monteros AL
  Treatment of hyperthyroidism with a combination of methimazole and cholestyramine. J Clin Endocrinol Metab. 1996 Sep;81(9):3191-3.
•   Migneco A, Ojetti V, Testa A, De Lorenzo A, Gentiloni Silveri N
  Management of thyrotoxic crisis. Eur Rev Med Pharmacol Sci. 2005 Jan-Feb;9(1):69-74. Review.
•   Nakamura H, Noh JY, Itoh K, Fukata S, Miyauchi A, Hamada N
  Comparison of methimazole and propylthiouracil in patients with hyperthyroidism caused by Graves' disease. J Clin Endocrinol Metab. 2007 Jun;92(6):2157-62. Epub 2007 Mar 27.
•   Ozawa Y, Daida H, Shimizu T, Shishiba Y
  Rapid improvement of thyroid function by using glucocorticoid indicated for the preoperative preparation of subtotal thyroidectomy in Graves' disease. Endocrinol Jpn. 1983 Feb;30(1):93-100.
•   Page SR, Sheard CE, Herbert M, Hopton M, Jeffcoate WJ
  A comparison of 20 or 40 mg per day of carbimazole in the initial treatment of hyperthyroidism. Clin Endocrinol (Oxf). 1996 Nov;45(5):511-6. Erratum in: Clin Endocrinol (Oxf) 1997 Feb;46(2):240.
•   Ross DS, Burch HB, Cooper DS, Greenlee MC, Laurberg P, Maia AL, Rivkees SA, Samuels M, Sosa JA, Stan MN, Walter MA
  2016 American Thyroid Association Guidelines for Diagnosis and Management of Hyperthyroidism and Other Causes of Thyrotoxicosis. Thyroid. 2016 Oct;26(10):1343-1421.
•   Solomon BL, Wartofsky L, Burman KD
  Adjunctive cholestyramine therapy for thyrotoxicosis. Clin Endocrinol (Oxf). 1993 Jan;38(1):39-43.
•   Sundaresh V, Brito JP, Wang Z, Prokop LJ, Stan MN, Murad MH, Bahn RS
  Comparative effectiveness of therapies for Graves' hyperthyroidism: a systematic review and network meta-analysis. J Clin Endocrinol Metab. 2013 Sep;98(9):3671-7. doi: 10.1210/jc.2013-1954. Epub 2013 Jul 3. Review.

A Multi-center, Open Label, Randomised Parallel- Group Study to Compare the Efficacy of Cholestyramine Plus Standard Treatment Versus Prednisolone Plus Standard Treatment Versus Standard Treatment Alone in Treatment of Overt Hyperthyroidism

Details for clinical trial NCT03303053